Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
ID: 354980Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCCDPHP (HHS-CDC-NCCDPHP)

Award Range

$1M - $2M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354980
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to support national organizations in reducing the time to lupus diagnoses, improving care coordination, and enhancing the quality of life for individuals living with lupus, particularly among underserved populations. The program will focus on two key strategies: increasing healthcare provider awareness and promoting effective lupus self-management tools. The total estimated funding for this program is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are expected to be submitted by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.

    Point(s) of Contact
    Stephanie Hinton
    (678) 938-9722
    qxk8@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting research proposals through a cooperative agreement to identify and evaluate potential risk factors for Amyotrophic Lateral Sclerosis (ALS). The opportunity encourages studies focusing on various aspects such as military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents, with four distinct funding options available to support both established and exploratory research. This initiative aims to enhance understanding of ALS risk factors, particularly in affected populations, and to analyze biological samples related to the Guamanian ALS cluster. Interested applicants can reach out to Dr. Candis Hunter at ncipcerpo@cdc.gov or by phone at 770-488-1347. The total estimated funding for this program is $7.5 million, with individual awards ranging from $0 to $500,000, and proposals are due by December 1, 2025, with awards expected to be announced by August 28, 2026.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Increasing awareness and knowledge of Alpha-gal Syndrome in the United States." The primary objective of this funding opportunity is to enhance awareness, surveillance, and patient care related to Alpha-gal Syndrome (AGS), an emerging health condition that is not nationally notifiable. The grant seeks to support the formation of a professional association to disseminate knowledge about AGS, create educational resources for both the public and healthcare providers, and conduct enhanced public health surveillance, with a total estimated program funding of $10 million and awards ranging from $25,000 to $1 million. Interested applicants, including bona fide agents, must submit their applications electronically by May 1, 2026, with an anticipated award date of July 1, 2026. For further inquiries, applicants can contact Jeff Borchert at gqx1@cdc.gov or by phone at (970) 221-6494.
    Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled "Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry." This initiative aims to collect high-quality longitudinal data on individuals with spina bifida through specialized clinics and to implement the Urologic Management to Preserve Initial Renal Function Protocol for young children with myelomeningocele. The funding, which ranges from $166,428 to $488,571 per award, totals approximately $2,330,000, with an expected 19 awards to be made. Interested applicants, particularly small businesses, should note that applications are due by March 16, 2026, with an estimated award date of August 11, 2026; for further inquiries, contact Stephanie Griswold at 404-718-2623 or via email at eut6@cdc.gov.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative seeks applications from bona fide agents representing state, territorial, local, and tribal government organizations, with the goal of implementing effective strategies to combat parasitic diseases. The total estimated program funding is $23,750,000, with individual awards ranging from $250,000 to $1,250,000, and a total of 11 awards expected to be made. Interested applicants should note that the application deadline is June 5, 2026, and they can reach out to Jamal Choice, the Project Officer, at 404.718.8228 or via email at qhi2@cdc.gov for further information.
    Comprehensive Suicide Prevention Program for States
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Comprehensive Suicide Prevention Program for States," aimed at implementing and evaluating a comprehensive approach to suicide prevention, particularly for disproportionately affected populations such as veterans, rural communities, and LGBTQ individuals. Eligible applicants must submit proposals with a funding request between $650,000 and $1,200,000, including various letters of commitment and support, as well as a preliminary organizational chart detailing required staff roles. The total estimated program funding is approximately $49.7 million, with an expected 42 awards to be made, and applications must be submitted electronically by 11:59 PM ET on March 3, 2026, with the anticipated award date set for June 19, 2026. For further inquiries, applicants can contact the Comprehensive Suicide Prevention mailbox at csp@cdc.gov.
    US Travelers Health Research, Surveillance, and Outreach Network
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "US Travelers Health Research, Surveillance, and Outreach Network" through a cooperative agreement aimed at enhancing pre-travel health consultations for international travelers. The primary objectives are to increase the proportion of travelers receiving essential health advice and vaccinations before traveling to areas at risk for infectious diseases, thereby improving the quality of healthcare provided during these consultations. Given the rise in international travel and associated health risks, this initiative is crucial for educating travelers on preventive measures against illnesses such as yellow fever and malaria. The total funding available for this program is $3 million, with individual awards ranging from $450,000 to $600,000. Interested applicants, particularly for-profit organizations, should note that applications are due by March 1, 2026, with an estimated award date of September 15, 2026. For further inquiries, contact Amy Yang at AYang@cdc.gov or call 404-718-8836.
    Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan." This initiative aims to gather unique data to enhance understanding of the resources and opportunities necessary to improve outcomes for individuals with autism and Fragile X Syndrome (FXS) throughout their lives. The program consists of three components: data collection on autistic teens and young adults, data collection on individuals with FXS, and dissemination of public health products to support these populations. The total estimated funding for this program is $18 million, with 11 awards expected to be made. Interested applicants can reach out to Seema Gupta at (770) 488-6527 or via email at cvk9@cdc.gov for further information. Applications must be submitted electronically by January 30, 2026, with the project anticipated to start on July 1, 2026.
    Influenza Modeling and Forecasting
    Centers for Disease Control - NCIRD
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Influenza Modeling and Forecasting" through a cooperative agreement aimed at enhancing the use of influenza modeling and forecasting to improve public health responses. The initiative seeks to establish a network that will provide situational awareness, inform prevention and control strategies, and advance the science of influenza forecasting, particularly for populations disproportionately affected by influenza. With an estimated total program funding of $14,750,000 and the expectation of awarding seven grants, interested applicants can reach out to Rebecca Borchering at 404.639.5214 or via email at xkq2@cdc.gov. Applications must be submitted electronically by February 2, 2026, with awards anticipated to be made by August 1, 2026.
    Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations" through a cooperative agreement. This initiative aims to support research that gathers timely economic data on immunization from nationally representative samples of the public, including patients and caregivers, to inform economic evaluations of new vaccines. The program is critical for understanding productivity losses related to immunization, particularly for vulnerable populations such as pregnant women and parents of young children. The estimated total funding for this program is $1.2 million, with individual awards ranging from $300,000 to $400,000. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 31, 2026, and project start anticipated on September 1, 2026.
    Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Eliminating Parasitic and Neglected Tropical Disease Threats to the United States," aimed at expanding its network of collaborating institutes for research and program support. The initiative seeks to achieve, accelerate, or maintain outcomes for the elimination or control of non-malaria parasitic threats and neglected tropical diseases that impact the health of Americans domestically and internationally. This cooperative agreement has an estimated total program funding of $10 million, with individual awards ranging from $500,000 to $666,667, and is expected to result in three awards. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 1, 2026, and awards anticipated by September 15, 2026.